Gui-Qi Zhu (Guiqi Zhu)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Systemic Sclerosis

Long Noncoding Rna

Top Venues

Science advances

Cancer communications (London, England)

Modern rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Jialiang Cai, Li-Na Song, Feng Zhang, Suiyi Wu, Gui-Qi Zhu, Peiling Zhang, Shiping Chen, Junxian Du, Biao Wang, Yufan Cai, Yi Yang, Jinglei Wan, Jian Zhou, Jia Fan, Zhi Dai
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer communications (London, England) (2024)
Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science advances 9 (17) (2023)
Jun Gao, Yuan Fang, Jiafeng Chen, Zheng Tang, Mengxin Tian, Xifei Jiang, Chenyang Tao, Run Huang, Gui-Qi Zhu, Weifeng Qu, Xiaoling Wu, Jian Zhou, Jia Fan, Weiren Liu, Ying-Hong Shi
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy. Oncogene (2023)
Weiren Liu, Huqiang Wang, Qianfu Zhao, Chenyang Tao, Weifeng Qu, Yushan Hou, Run Huang, Zimei Sun, Gui-Qi Zhu, Xifei Jiang, Yuan Fang, Jun Gao, Xiaoling Wu, Zhixiang Yang, Rongyu Ping, Jiafeng Chen, Rui Yang, Tianhao Chu, Jian Zhou, Jia Fan, Zheng Tang, Dong Yang, Yinghong Shi
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. Cancer communications (London, England) 44 (2) (2023)
Pei-Yun Zhou, Cheng Zhou, Wei Gan, Zheng Tang, Bao-Ye Sun, Jin-Long Huang, Gao Liu, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Yuan Fang, Wei-Feng Qu, Run Huang, Gui-Qi Zhu, Cheng Huang, Xiu-Tao Fu, Zhen-Bin Ding, Qiang Gao, Jian Zhou, Ying-Hong Shi, Yong Yi, Jia Fan, Shuang-Jian Qiu
Single-cell and spatial architecture of primary liver cancer. Communications biology 6 (1) (2023)
Weiren Liu, Huqiang Wang, Qianfu Zhao, Chenyang Tao, Weifeng Qu, Yushan Hou, Run Huang, Zimei Sun, Gui-Qi Zhu, Xifei Jiang, Yuan Fang, Jun Gao, Xiaoling Wu, Zhixiang Yang, Rongyu Ping, Jiafeng Chen, Rui Yang, Tianhao Chu, Jian Zhou, Jia Fan, Zheng Tang, Dong Yang, Yinghong Shi
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. Cancer communications (London, England) 44 (2) (2023)
Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science advances 9 (17) (2023)
Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science advances 9 (17) (2023)
Weiren Liu, Huqiang Wang, Qianfu Zhao, Chenyang Tao, Weifeng Qu, Yushan Hou, Run Huang, Zimei Sun, Gui-Qi Zhu, Xifei Jiang, Yuan Fang, Jun Gao, Xiaoling Wu, Zhixiang Yang, Rongyu Ping, Jiafeng Chen, Rui Yang, Tianhao Chu, Jian Zhou, Jia Fan, Zheng Tang, Dong Yang, Yinghong Shi
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. Cancer communications (London, England) 44 (2) (2023)
Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science advances 9 (17) (2023)
Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science advances 9 (17) (2023)
Weiren Liu, Huqiang Wang, Qianfu Zhao, Chenyang Tao, Weifeng Qu, Yushan Hou, Run Huang, Zimei Sun, Gui-Qi Zhu, Xifei Jiang, Yuan Fang, Jun Gao, Xiaoling Wu, Zhixiang Yang, Rongyu Ping, Jiafeng Chen, Rui Yang, Tianhao Chu, Jian Zhou, Jia Fan, Zheng Tang, Dong Yang, Yinghong Shi
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. Cancer communications (London, England) (2023)
Yi Yang, Qing Chen, Hai-Yan Piao, Biao Wang, Gui-Qi Zhu, Er-Bao Chen, Kun Xiao, Zheng-Jun Zhou, Guo-Ming Shi, Ying-Hong Shi, Wei-Zhong Wu, Jia Fan, Jian Zhou, Zhi Dai
HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma. International journal of cancer 146 (1) (2019)
Ji-Na Zheng, Qiao-Rong Yang, Gui-Qi Zhu, Lin Pan, Jing-Xian Xia, Qiang Wang
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis. Modern rheumatology 30 (4) (2019)